Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis.

Han, Xiaoxuan; Li, Danni; Reyes-Ortega, Felisa; Schneider-Futschik, Elena K

Han, Xiaoxuan; Li, Danni; Reyes-Ortega, Felisa; Schneider-Futschik, Elena K.

Afiliação

Han X; Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.
Li D; Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.
Reyes-Ortega F; Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.
Schneider-Futschik EK; Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia.

Pharmaceutics ; 15(5)2023 May 13.

Article em En | MEDLINE | ID: mdl-37242730

Palavras-chave

clinical factors; cystic fibrosis; dry powder formulation; pulmonary medicines; respiratory delivery

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google